We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Stock Drops Despite Market Gains: Important Facts to Note
Read MoreHide Full Article
In the latest trading session, Albemarle (ALB - Free Report) closed at $133.80, marking a -1.3% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.72%. On the other hand, the Dow registered a gain of 0.3%, and the technology-centric Nasdaq increased by 1.12%.
Prior to today's trading, shares of the specialty chemicals company had lost 12.79% lagged the Basic Materials sector's loss of 5.59% and the S&P 500's loss of 0.9%.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. On that day, Albemarle is projected to report earnings of $3.21 per share, which would represent year-over-year growth of 2818.18%. Our most recent consensus estimate is calling for quarterly revenue of $1.53 billion, up 15.08% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $12.98 per share and a revenue of $6.11 billion, indicating changes of +1743.04% and +18.78%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Albemarle. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 4.8% higher. Albemarle is currently a Zacks Rank #1 (Strong Buy).
In the context of valuation, Albemarle is at present trading with a Forward P/E ratio of 10.44. This indicates a discount in contrast to its industry's Forward P/E of 15.82.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Albemarle (ALB - Free Report) closed at $133.80, marking a -1.3% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.72%. On the other hand, the Dow registered a gain of 0.3%, and the technology-centric Nasdaq increased by 1.12%.
Prior to today's trading, shares of the specialty chemicals company had lost 12.79% lagged the Basic Materials sector's loss of 5.59% and the S&P 500's loss of 0.9%.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. On that day, Albemarle is projected to report earnings of $3.21 per share, which would represent year-over-year growth of 2818.18%. Our most recent consensus estimate is calling for quarterly revenue of $1.53 billion, up 15.08% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $12.98 per share and a revenue of $6.11 billion, indicating changes of +1743.04% and +18.78%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Albemarle. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 4.8% higher. Albemarle is currently a Zacks Rank #1 (Strong Buy).
In the context of valuation, Albemarle is at present trading with a Forward P/E ratio of 10.44. This indicates a discount in contrast to its industry's Forward P/E of 15.82.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.